Association of CTLA-4 (rs231775) and FOXP3 (rs3761548) Gene Polymorphisms with Type 1 Diabetes in Iraqi Kurdish Children
DOI:
https://doi.org/10.22317/jcms.v12i1.2115Keywords:
Diabetes Mellitus, Type 1, CTLA-4 Antigen, FOXP3, Polymorphism, Genetic, AutoimmunityAbstract
Objective: The objective of the current research was to determine the correlation between FOXP3 (rs3761548) and CTLA-4 (rs231775) gene polymorphisms and Type 1 Diabetes susceptibility among children of the Iraqi-Kurdish population.
Methods: A total of 140 pediatric participants (70 with T1D and 70 age- and sex-matched controls) were recruited in this study. Whole blood taken at the periphery was subjected to genomic DNA extraction using the Qiagen DNA Extraction Kit (Qiagen, Hilden, Germany). Amplification of the specific genomic regions containing the target polymorphisms CTLA4 rs231775 and FOXP3 rs3761548 was performed through polymerase chain reaction (PCR). The presence of the PCR product and the amplicon size was confirmed using the QIAxcel Advanced System (QIAGEN GmbH, Hilden, Germany). The confirmed products were then sent for Sanger sequencing.
Results: The CTLA-4 rs231775 variant was statistically significant at the genotype level (P = 0.039) and under the dominant inheritance model (P = 0.017); the allele G seemed to have a higher frequency in the patients. In contrast, a sex-stratified analysis across the X-linked FOXP3 3761548 polymorphism showed no statistically significant association with T1D either female or male subjects.
Conclusions: The current study demonstrates that the CTLA 4 rs231775 polymorphism, specifically the AG genotype and G allele is correlated with the susceptibility to T1D in the children of Iraqi Kurdish population, but the X-linked FOXP3 variant is not statistically significant.
References
Lemos JR, Hirani K, von Herrath M. Immunological and virological triggers of type 1 diabetes: insights and implications. Frontiers in Immunology. 2024;14:1326711.
Hussein S, Bandarian F, Salehi N, Khah AM, Motevaseli E, Azizi ZJC. The effect of vitamin D deficiency on immune-related hub genes: a network analysis associated with type 1 diabetes. 2024;16(9):e68611.
Aamodt KI, Powers AC. The pathophysiology, presentation and classification of Type 1 diabetes. Diabetes, Obesity Metabolism. 2025;27:15-27.
Bender C, Rajendran S, Von Herrath MG. New insights into the role of autoreactive CD8 T cells and cytokines in human type 1 diabetes. Frontiers in endocrinology. 2021;11:606434.
Redondo MJ, Morgan NG. Heterogeneity and endotypes in type 1 diabetes mellitus. Nature Reviews Endocrinology. 2023;19(9):542-54.
Hussein S, Mahmoudi-aznaveh A, Nekoeian S, Qurbani K, Panji M, Zakeri P, et al. Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation. Molecular Biology Reports. 2025;52(1):939.
Noble JA, Valdes AM. Genetics of the HLA region in the prediction of type 1 diabetes. Current diabetes reports. 2011;11(6):533-42.
Omar TA, El Rafeh El Bassuoni MA, Zouna ZSA, El Desokey EKA, El Maghraby AS. Evaluation the Role of Cytotoxic T-lymphocyte Antigen-4 (rs231775) Gene Polymorphism in Patients with Type 1 Diabetes Mellitus. Egyptian Journal of Hospital Medicine. 2025(100).
He Y, Na H, Li Y, Qiu Z, Li W. FoxP3 rs3761548 polymorphism predicts autoimmune disease susceptibility: a meta-analysis. Human immunology. 2013;74(12):1665-71.
Hossen MM, Ma Y, Yin Z, Xia Y, Du J, Huang JY, et al. Current understanding of CTLA-4: from mechanism to autoimmune diseases. Frontiers in Immunology. 2023;14:1198365.
Wang B, Du W, Jia Y, Zhang X, Ma G. Cytotoxic T-lymphocyte-associated protein 4+ 49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis. Oncotarget. 2017;8(6):10553.
Pang H, Luo S, Huang G, Li X, Xie Z, Zhou Z. The Association of CTLA-4 rs231775 and rs3087243 polymorphisms with latent autoimmune diabetes in adults: a Meta-analysis. Biochemical Genetics. 2022;60(4):1222-35.
Lu L, Barbi J, Pan F. The regulation of immune tolerance by FOXP3. Nature Reviews Immunology. 2017;17(11):703-17.
Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38(3):414-23.
Abdelsalam M, Zohdy M, Wassefy M, Salamony A, Elmansoury E, Mostafa MJBoPSAU. Association between FOXP3 (RS3761548) promoter polymorphism with vitiligo patients, their clinical data and response to phototherapy: a study from Egypt. 2022;45(2):833-43.
Li H-n, Li X-r, Du Y-y, Yang Z-f, Lv Z-t. The association between Foxp3 polymorphisms and risk of graves' disease: A systematic review and meta-analysis of observational studies. Frontiers in endocrinology. 2020;11:392.
Hernández-Bello J, Preciado-Aguiar MS, Muñoz-Valle JF, Baños-Hernández CJ, García-Arellano S, Alvarado-Navarro A. Influence of FOXP3 rs2280883 and rs3761548 Variants on IL-10 and TGF-β1 Serum Levels and Plaque Psoriasis Risk in the Mexican Population. International Journal of Molecular Sciences. 2025;26(5):1789.
Tan G, Zheng G, Li J, Zhu Y, Liang Z, Li H, et al. Association of genetic variations in FoxP3 gene with Graves' disease in a Southwest Chinese Han population. Immunity, Inflammation Disease. 2023;11(10):e1046.
Bassuny WM, Ihara K, Sasaki Y, Kuromaru R, Kohno H, Matsuura N, et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics. 2003;55(3):149-56.
Iwase K, Shimada A, Kawai T, Okubo Y, Kanazawa Y, Irie J, et al. FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese, especially in women and slowly progressive-type patients. Autoimmunity. 2009;42(2):159-67.
Urrutia I, Martinez R, Calvo B, Marcelo I, Saso-Jimenez L, Martinez de Lapiscina I, et al. Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age. Frontiers in Endocrinology. 2024;15:1411686.
Hawi ZA, Pugsley K, Namipashaki A, Samarrai W, Hawi ZJIA-HJfP, Sciences A. A review of consanguinity in the Iraqi population: A call to action to prevent a future health catastrophe. 2024;37(2):64-70.
Kheiralla KEK. CTLA-4 (+ 49A/G) polymorphism in type 1 diabetes children of Sudanese population. Global Medical Genetics. 2021;8(01):011-8.
Ebrahim E, Teklu T, Tajebe F, Wondmagegn T, Akelew Y, Fiseha M, et al. Association of cytotoxic T-lymphocyte antigen-4 gene polymorphism with type 1 diabetes mellitus: In silico analysis of biological features of CTLA-4 protein on Ethiopian population. Diabetes, Metabolic Syndrome. 2022:2733-51.
Obaied MHR, Ozer N, Alawneh HIF, Dalmizrak O. Implication of the HLA-DQA1, HLA-DQB1 and CTLA-4 alleles in the susceptibility to type 1 diabetes in Jordanian population. Molecular Biology Reports. 2025;52(1):1-8.
Sousa M, Welter M, Machado E, Tonet G, Campos L, Nesi-França S, et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) rs231775 and rs5792909 polymorphisms are not associated with adult-and childhood-onset type 1 diabetes in a Southern Brazilian population. Genetics and Molecular Research 2021;20(2).
Ren D, He L, Pang X. Association of CLTA-4 gene polymorphisms with diabetes mellitus: a study based on the Han population of Northern China. Diabetes, Metabolic Syndrome Obesity: Targets Therapy
:2705-12.
Zavattari P, Deidda E, Pitzalis M, Zoa B, Moi L, Lampis R, et al. No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes. 2004;53(7):1911-4.
Bjørnvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jørgensen K, Njølstad PR, et al. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. Journal of autoimmunity. 2006;27(2):140-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
